Cita APA (7a ed.)

Z, L., W, H., Y, Y., D, L., Z, X., Z, L., & M, Y. (2021). LncRNA ADAMTS9-AS2 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Lung Adenocarcinoma. Dove Medical Press.

Cita Chicago Style (17a ed.)

Z, Lin, Huang W, Yi Y, Li D, Xie Z, Li Z, y Ye M. LncRNA ADAMTS9-AS2 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Lung Adenocarcinoma. Dove Medical Press, 2021.

Cita MLA (8a ed.)

Z, Lin, et al. LncRNA ADAMTS9-AS2 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Lung Adenocarcinoma. Dove Medical Press, 2021.

Precaución: Estas citas no son 100% exactas.